myirislogo
29 January, 2015 03:42 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Hindalco In 140.20 3.14
State Bank O 334.45 2.17
Icici Bank 383.85 3.62
Axis Bank 590.60 4.53
Tata Stl 390.90 2.92
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Ipca Laboratories Limited
Ipca Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524494NSE:IPCALABBloomberg:IPCA@INReuters:IPCA.BO
Market Lot: 1Face Value: 2ISIN Demat: INE571A01020
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
01-DEC-14 CRISIL enhanced rated amount while retaining `AA/Stable/A1+` ratings on on Ipca Laboratories Rs 500-million non-convertible debenture issue on the company`s request as there is no CRISIL-rated instrument currently outstanding in the programme. The rated amount enhanced to Rs 500 million from Rs 210million. 01-OCT-14 IPCA Laboratories, a Mumbai-based drugmaker, announced that the company has acquired as a going concern on slump sale b...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
CRISIL enhances rated amount for Ipca Laboratories  -IRIS 01-Dec-14
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Mar-2014 (12)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 31817.6027388.2022992.40
Other Income214.30186.60129.20
Total Income32031.9027574.8023121.60
Cost of goods sold24295.9021571.3018158.90
OPBDIT7736.006003.504962.70
PAT4773.703313.902801.70
Gross Block---
Equity capital252.40252.40252.30
EPS (Rs.)37.8326.2722.23
DPS (Rs.)---
BV (Rs.)---
P/E range (x)13.01 - 23.9712.19 - 21.5810.36 - 15.83
Debt / Equity (x)---
Operating margin (% of OI)24.221.821.5
Net margin (% of OI)14.912.012.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
48, Kandivli Industrial Estate
Kandivli (West)
Mumbai
Maharashtra-400 067
PHONE
(022) 6647 4444
FAX
(022) 2868 6613
 
Board of Directors
Board Meetings
Date Purpose
07-FEB-15 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer